Literature DB >> 28859567

The hypothalamus at the crossroads of psychopathology and neurosurgery.

Daniel A N Barbosa1,2, Ricardo de Oliveira-Souza1,3, Felipe Monte Santo1,4, Ana Carolina de Oliveira Faria1,3, Alessandra A Gorgulho5,6, Antonio A F De Salles5,6.   

Abstract

The neurosurgical endeavor to treat psychiatric patients may have been part of human history since its beginning. The modern era of psychosurgery can be traced to the heroic attempts of Gottlieb Burckhardt and Egas Moniz to alleviate mental symptoms through the ablation of restricted areas of the frontal lobes in patients with disabling psychiatric illnesses. Thanks to the adaptation of the stereotactic frame to human patients, the ablation of large volumes of brain tissue has been practically abandoned in favor of controlled interventions with discrete targets. Consonant with the role of the hypothalamus in the mediation of the most fundamental approach-avoidance behaviors, some hypothalamic nuclei and regions, in particular, have been selected as targets for the treatment of aggressiveness (posterior hypothalamus), pathological obesity (lateral or ventromedial nuclei), sexual deviations (ventromedial nucleus), and drug dependence (ventromedial nucleus). Some recent improvements in outcomes may have been due to the use of stereotactically guided deep brain stimulation and the change of therapeutic focus from categorical diagnoses (such as schizophrenia) to dimensional symptoms (such as aggressiveness), which are nonspecific in terms of formal diagnosis. However, agreement has never been reached on 2 related issues: 1) the choice of target, based on individual diagnoses; and 2) reliable prediction of outcomes related to individual targets. Despite the lingering controversies on such critical aspects, the experience of the past decades should pave the way for advances in the field. The current failure of pharmacological treatments in a considerable proportion of patients with chronic disabling mental disorders is reminiscent of the state of affairs that prevailed in the years before the early psychosurgical attempts. This article reviews the functional organization of the hypothalamus, the effects of ablation and stimulation of discrete hypothalamic regions, and the stereotactic targets that have most often been used in the treatment of psychopathological and behavioral symptoms; finally, the implications of current and past experience are presented from the perspective of how this fund of knowledge may usefully contribute to the future of hypothalamic psychosurgery.

Entities:  

Keywords:  CCH = chronic cluster headache; DBS = deep brain stimulation; DMN = dorsomedial nucleus; ICAP = Inventory for Client and Agency Planning; LHA = lateral hypothalamic area; MOAS = Modified OAS; OAS = Overt Aggression Scale; PM = posteromedial; PMH = posteromedial hypothalamus; PON = preoptic nuclei; PVZ = periventricular zone; QOLS = Quality of Life Scale; VM = ventromedial; VMH = ventromedial hypothalamus; VPH = ventroposterior hypothalamus; deep brain stimulation; hypothalamus; mental disorders; psychosurgery

Mesh:

Year:  2017        PMID: 28859567     DOI: 10.3171/2017.6.FOCUS17256

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  6 in total

1.  High-Resolution Depth-Encoding PET Detector Module with Prismatoid Light-Guide Array.

Authors:  Andy LaBella; Xinjie Cao; Eric Petersen; Rick Lubinsky; Anat Biegon; Wei Zhao; Amir H Goldan
Journal:  J Nucl Med       Date:  2020-02-28       Impact factor: 10.057

Review 2.  Deep Brain Stimulation for Obesity: A Review and Future Directions.

Authors:  Douglas A Formolo; Joana M Gaspar; Hiago M Melo; Tuany Eichwald; Ramiro Javier Zepeda; Alexandra Latini; Michael S Okun; Roger Walz
Journal:  Front Neurosci       Date:  2019-04-18       Impact factor: 4.677

3.  Reelin is modulated by diet-induced obesity and has direct actions on arcuate proopiomelanocortin neurons.

Authors:  Brandon L Roberts; Baylin J Bennett; Camdin M Bennett; Julie M Carroll; Louise S Dalbøge; Colin Hall; Wafa Hassouneh; Kristy M Heppner; Melissa A Kirigiti; Sarah R Lindsley; Katherine G Tennant; Cadence A True; Andrew Whittle; Anitra C Wolf; Charles T Roberts; Mads Tang-Christensen; Mark W Sleeman; Michael A Cowley; Kevin L Grove; Paul Kievit
Journal:  Mol Metab       Date:  2019-06-08       Impact factor: 7.422

4.  Cell non-autonomous regulation of health and longevity.

Authors:  Hillary A Miller; Elizabeth S Dean; Scott D Pletcher; Scott F Leiser
Journal:  Elife       Date:  2020-12-10       Impact factor: 8.140

Review 5.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

6.  A high-resolution in vivo magnetic resonance imaging atlas of the human hypothalamic region.

Authors:  Clemens Neudorfer; Jürgen Germann; Gavin J B Elias; Robert Gramer; Alexandre Boutet; Andres M Lozano
Journal:  Sci Data       Date:  2020-09-15       Impact factor: 6.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.